Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
Ghobrial RM, Colquhoun S, Rosen H, Hollis P, Ponthieux S, Pakrasi A, Farmer DG, Markman JF, Markowitz J, Drazan K, Yersiz H, Singer J, Stribling R, Arnout W, Holt CD, Goss J, Imagawa D, Seu P, Goldstein LI, Shackleton CR, Martin P, Busuttil RW. Ghobrial RM, et al. Among authors: holt cd. Transplant Proc. 1998 Jun;30(4):1470-1. doi: 10.1016/s0041-1345(98)00320-0. Transplant Proc. 1998. PMID: 9636597 No abstract available.
Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
Ghobrial RM, Farmer DG, Baquerizo A, Colquhoun S, Rosen HR, Yersiz H, Markmann JF, Drazan KE, Holt C, Imagawa D, Goldstein LI, Martin P, Busuttil RW. Ghobrial RM, et al. Ann Surg. 1999 Jun;229(6):824-31; discussion 831-3. doi: 10.1097/00000658-199906000-00009. Ann Surg. 1999. PMID: 10363896 Free PMC article.
An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
Han SH, Ofman J, Holt C, King K, Kunder G, Chen P, Dawson S, Goldstein L, Yersiz H, Farmer DG, Ghobrial RM, Busuttil RW, Martin P. Han SH, et al. Liver Transpl. 2000 Nov;6(6):741-8. doi: 10.1053/jlts.2000.18702. Liver Transpl. 2000. PMID: 11084061 Free article.
Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin.
Imagawa DK, Dawson S 3rd, Holt CD, Kirk PS, Kaldas FM, Shackleton CR, Seu P, Rudich SM, Kinkhabwala MM, Martin P, Goldstein LI, Murray NG, Terasaki PI, Busuttil RW. Imagawa DK, et al. Among authors: holt cd. Transplantation. 1996 Oct 15;62(7):934-42. doi: 10.1097/00007890-199610150-00011. Transplantation. 1996. PMID: 8878387
Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation.
Han SH, Martin P, Edelstein M, Hu R, Kunder G, Holt C, Saab S, Durazo F, Goldstein L, Farmer D, Ghobrial RM, Busuttil RW. Han SH, et al. Liver Transpl. 2003 Feb;9(2):182-7. doi: 10.1053/jlts.2003.50002. Liver Transpl. 2003. PMID: 12548512 Free article.
42 results